Mark Sheptoff Financial Planning, LLC Dbv Technologies S.A. Transaction History

Mark Sheptoff Financial Planning, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2020 May 07, 2020	SELL	$2.33 - $12.98 $2,330 - $12,980	-1,000 Reduced 76.92%	300 $1,000
Q4 2019 Feb 10, 2020	BUY	$6.75 - $11.15 $8,775 - $14,495	1,300 New	1,300 $14,000

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $792M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Mark Sheptoff Financial Planning, LLC, based on Form 13F filings with the SEC.

Stay updated on Mark Sheptoff Financial Planning, LLC with notifications on news.